Y-Intercept (HK)
SNY icon

Y-Intercept (HK)’s Sanofi SNY Stock Holding History

Y-Intercept (HK)’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-24,073
Closed -$1.03M – 2063
2026
Q2 		$1.03M Buy
24,073
+17,581
+271% +$786K 0.02% 1042
2026
Q1 		$313K Sell
6,492
-67,064
-91% -$3.13M 0.01% 1366
2025
Q4 		$3.56M Buy
73,556
+55,631
+310% +$2.76M 0.08% 350
2025
Q3 		$846K Sell
17,925
-64,283
-78% -$3.1M 0.02% 1055
2025
Q2 		$3.97M Buy
+82,208
New +$4.2M 0.1% 295

Other funds holding SNY

Mondrian Investment Partners
Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
Todd Asset Management
Todd Asset Management Louisville, Kentucky $5.51B AUM 33.77% 1-Year Est. Return
Willis Investment Counsel
Willis Investment Counsel Gainesville, Georgia $1.97B AUM 25.29% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Grandfield & Dodd
Grandfield & Dodd New York $1.87B AUM 27.26% 1-Year Est. Return
Foundation Resource Management
Foundation Resource Management Little Rock, Arkansas $939M AUM 37.7% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
Oppenheimer Asset Management
Oppenheimer Asset Management New York $9.5B AUM 23.46% 1-Year Est. Return

Y-Intercept (HK)'s SNY Position: Q3 2026 in Review

Y-Intercept (HK) sold out of Sanofi (SNY) in Q3 2026, closing a stake of 24,073 shares — an estimated $1.03M sold.

Y-Intercept (HK) first reported a position in SNY in Q2 2025 and held it in 5 quarters. The position peaked at $3.97M in Q2 2025. 249 funds tracked by Wall St. Rank hold SNY as of Q3 2026.

  • Y-Intercept (HK) reported no remaining Sanofi position as of Q3 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 24,073 Sanofi shares in Q3 2026, an estimated $1.03M.
  • Y-Intercept (HK) first reported a position in Sanofi in Q2 2025 and held it in 5 quarters.
  • Y-Intercept (HK)'s Sanofi position peaked at $3.97M in Q2 2025.
  • 249 funds tracked by Wall St. Rank held Sanofi as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.